Ginseng in Type 2 Diabetes Mellitus: A Review of the Evidence in Humans

Nutraceuticals, Glycemic Health and Type 2 Diabetes

Volumn , Issue , 2009, Pages 245-292

  Sievenpiper, John L ^a,b   Jenkins, Alexandra L ^a,b   Dascalu, Anamarie ^a,b   Stavro, P Mark ^a,b   Vuksan, Vladimir ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

American Ginseng Clinical Testing Program; Antihypertensive effects of ginseng batch; Complementary and alternative medicine (CAM); Dammarane type triterpene glycosides; Ginsenosides; Korean Red Ginseng Clinical Testing Program

Indexed keywords

EID: 84889280503     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780813804149.ch12     Document Type: Chapter

References (99)

1. American Diabetes Association. 2007. Diagnosis and classification of diabetes mellitus. Diabetes Care 29:s43-s48.
2. Angell M, Kassirer JP. 1998. Alternative Medicine-the risks of untested and unregulated remedies. N Engl J Med 339:839-841.
3. Anonymous. Efficacy of ginseng. 2005. Controls diabetes mellitus. The medicinal effects of Korean red ginseng. Available at http://www.kgc.or.kr/eng/04r&d/r&d efficacy01.html. Accessed on February 1, 2005.
4. Attele AS, Wu JA, Yuan CS. 1999. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem Pharmacol 58:1685-1693.
5. Attele AS, Zhou YP, Xie JT, Wu JA, Zhang L, Dey L, Pugh W, Rue PA, Polonsky KS, Yuan CS. 2002. Antidiabetic effects of Panax ginseng berry extract and the identification of an effective component. Diabetes 51:1851-1858.
6. Awang DVC. 2000. The neglected ginsenosides of North American ginseng (Panax quinquefolius L.). J Herbs Spices Med Plants 7:103-109.
7. Buettner C, Phillips RS,DavisRB, Gardiner P, MittlemanMA.2007. Use of dietary supplements among United States adults with coronary artery disease and atherosclerotic risks. Am J Cardiol 99:661-666.
8. Byun BH, Shin I, Yoon YS, Kim SI, Joe CO. 1997. Modulation of protein kinase C activity in NIH 3T3 cells by plant glycosides from Panax ginseng. Planta Med 63:389-392.
9. Caron MF, Hotsko AL, Robertson S, Mandybur L, Kluger J, White CM. 2002. Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother 36:758-763.
10. Chen SE, Sawchuk RJ, Staba EJ. 1980. American ginseng. III. Pharmacokinetics of ginsenosides in the rabbit. Eur J Drug Metab Pharmacokinet 5:161-168.
11. Cho JY, Yoo ES, Baik KU, Park MH, Han BH. 2001. In vitro inhibitory effect of protopanaxadiol ginsenosides on tumor necrosis factor (TNF)-alpha production and its modulation by known TNF-alpha antagonists. Planta Med 67:213-218.
12. Chung SH, Choi CG, Park SH. 2001. Comparisons between white ginseng radix and rootlet for antidiabetic activity and mechanism in KKAy mice. Arch Pharm Res 24:214-218.
13. Cui JF. 1995. Identification and quantification of ginsenosides in various commercial ginseng preparations. Eur J Pharm Sci 3:77-85.
14. Dascalu A, Sievenpiepr JL, Arnason JT, Leiter LA, Vuksan V. 2007. Five Batches Representative of Ontario-grown American Ginseng Root (Panax quinquefolius L.) Produce Comparable Reductions of Postprandial Glycemia in Healthy Individuals. Can J Physiol Pharmacol 85:856-864.
15. Eisenberg DM, Davis RB, Ettner SL, Appel S,Wilkey S, Van RompayM, Kessler RC. 1998. Trends in Alternative Medicine use in the United States, 1900-1997: Results of a Follow-up National Survey. JAMA 280:1569-1575.
16. Fitzloff JF,Yat P, Lu ZZ,AwangDVC, Arnason JT, van Breeman RB, Hall T, Blumethal M, Fong HHS. 1998. Perspectives on the quality control assurance of ginseng products in North America. In Advances in Ginseng Research: Proceedings of the 7th International Symposium on Ginseng, edited by Huh H, Choi KJ, Kim YC, pp. 138-145. Seoul, Korea: Korean Society of Ginseng.
17. Han KH, Choe SC, Kim HS, Sohn DW, Nam KY, Oh BH, Lee MM, Park YB, Choi YS, Seo JD, LeeYW. 1998. Effect of red ginseng on blood pressure in patients with essential hypertension and white coat hypertension. Am J Chin Med 26:199-209.
18. Han HJ, Park SH, Koh HJ, Nah SY, Shin DH, Choi HS. 1999. Protopanaxatriol ginsenosides inhibit glucose uptake in primary cultured rabbit renal proximal tubular cells by arachidonic acid release. Kidney Blood Press Res 22:114-120.
19. Han KH, Shin IC, Choi KJ, Yun YP, Hoing JT, Oh KW. 2005. Korean red ginseng water extract increased nitric oxide concentrations in exhaled breath. Nitric Oxide 12:159-162.
20. Hasegawa H, Matsumiya S, Murakami C, Kurokawa T, Kasai R, Ishibashi S, Yamasaki K. 1994. Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes. Planta Med 60:153-157.
21. Hasegawa H, Sung JH, Matsumiya S, Uchiyama M. 1996. Main ginseng saponin metabolites formed by intestinal bacteria. Planta Med 62:453-457.
22. Hitonobu IW, Masatoshi Y, Kimura M. 1982. Effects of hypoglycmic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharm Dyn 5:547-554.
23. Hong SJ, Fong JC, Hwang JH. 2000. Effects of crude drugs on glucose uptake in 3T3-L1 adipocytes. Kaohsiung J Med Sci 16:445-451.
24. Jenkins AL, Morgan L, Bishop J, Zdravkovc U, Di Buono M, Vuksan V. 2002a. Insulin sparing effect of Konjac mannan fiber when used in combination with American ginseng in type 2 diabetes. FASEB J 16:A647.
25. Jenkins AL, Morgan L, Bishop J, Zdravkovc U, Vuksan V. 2002b. Reduced glycemia of second meal with Konjac mannan fiber with or without American ginseng in type 2 diabetes. Diabetes 51(Suppl 2):A601.
26. Jenkins AL, Morgan L, Bishop J, Zdravkovc U, Vuksan V. 2003a. Reduction in HbA1c after long-term administration of American ginseng and Konjac mannan fiber in type diabetes. Diabetes 52(Suppl 1):A386.
27. Jenkins AL, Morgan L, Zdravkovic U, Naeem, A, Sievenpiper JL, Vuksan V. 2003b. Improved metabolic control after long-term treatment with American Ginseng and Konjac mannan fiber in type 2 diabetes. Can J Diabetes 27:357.
28. Joo C-N, Kim JH. 1992. Study on the hypoglycemic action of ginseng saponin on strepozotocin induced diabetic rats. Korean J Ginseng Sci 16:190-197.
29. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group. 2006. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443.
30. Kajiwara H, Hemmings AM, Hirano H. 1996. Evidence of metal binding activities of pentadecapeptide from Panax ginseng. J Chromatogr B 687:443-448.
31. Kimura M, Isami W, Tanaka O, Nagi Y, Shibita S. 1981a. Pharmacological sequential trials for the fraction of components with hypoglycemic activity in alloxan diabetic mice from ginseng radix. J Pharm Dyn 4:402-409.
32. Kimura M, Waki I, Chujo T, Kikuchi T, Hiyama C, Yamazaki K, Tanaka O. 1981b. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and one insulin release from perfused rat pancreas. J Pharm Dyn 4:410-417.
33. Konno C, Sugimyama K, Kano M, Hikino H. 1984. Isolation and hypoglycemic activity of panaxans A, B, C, D, and E glycans of Panax ginseng roots. Planta Med 50:434-436.
34. Li G, Lu Z. 1987. Effect of ginseng saponins on insulin release from isolated pancreatic islets of rats. Zhongguo Zhong Xi Yi Jie He Za Zhi 7:357-359.
35. Li TSC, Mazza G, Cottrell AC, Gao L. 1996. Ginsenosides in roots and leaves of American ginseng. J Agric Food 44:717-720.
36. LiW, Gu C, Zhang H, Awang DV, Fitzloff JF, Fong HH, van Breemen RB. 2000. Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Anal Chem 72:5417-5422.
37. Lipscombe LL, Hux JE. 2007. Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995-2005: A population-based study. Lancet 369:750-756.
38. Ma Y, Mai L, Malley L, Doucet M. 1996. Distribution and proportion of major ginsenosides and quality control of ginseng products. Chin J Med Chem 6:11-21.
39. Martinez B, Staba EJ. 1984. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats. Jpn J Pharmacol 35:79-85.
40. Mihalov JJ, Marsderosian AD, Pierce JC. 2000. DNA identification of commercial ginseng samples. J Agric Food Chem 48:3744-3752.
41. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. 2003. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79.
42. Nathan DM. 2006. Thiazolidinediones for initial treatment of type 2 diabetes? N Engl J Med 355:2477-2479.
43. NgTB,YeungHW. 1985. Hypoglycemic constituents ofPanax ginseng. Gen Pharmacol 16:549-552.
44. Nguyen MD, Kasai R, Ohtani K, Ito A, Nguyen TN, Yamasaki K, Tanaka O. 1994. Saponins from Vietnamese Ginseng, Panax vietnamensis HA et Grushv. Collected in central Vietnam. II. Chem Pharm Bull 42:115-122.
45. Nissen SE,Wolski K. 2007. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 356:2457-2471. Erratum in: N Engl J Med 2007;357:100.
46. Ohnishi Y, Takagi S, Miura T, Usami M, Kako M, Ishihara E, Yano H, Tanigawa K, Seino Y. 1996. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice. Biol Pharm Bull 19:1238-1240.
47. Onomura M, Tsukada H, Fukuda K, Hosokawa M, Nakamura H, Kodama M, Ohya M, Seino Y. 1999. Effects of ginseng radix on sugar absorption in the small intestine. Am J Chin Med 27:347-354.
48. Reay JL, Kennedy DO, Scholey AB. 2005. doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol. 19(4):357-365.
49. Reay JL, Kennedy DO, Scholey AB. 2006a. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained "mentally demanding" tasks. J Psychopharmacol 20:771-781.
50. Reay JL, Kennedy DO, Scholey AB. 2006b. The glycaemic effects of single doses of Panax ginseng in young healthy volunteers. Br J Nutr 96:639-642.
51. Ren G, Chen F. 1999. Simultaneous quantification of ginsenosides in American ginseng (Panax quinquefolium) root powder by visible/near-infrared reflectance spectroscopy. J Agric Food Chem 47:2771-2775.
52. Samira MM, Attia MA, Allam M, Elwan O. 1985. Effect of the standardized Ginseng Extract G115 on the metabolism and electrical activity of the rabbit's brain. J Int Med Res 13:342-348.
53. Shia GT, Ali S, Bittles AH. 1982. The effects of ginseng saponins on the growth and metabolism of human diploid fibroblasts. Gerontology 28:121-124.
54. Sievenpiper JL, Arnason JT, Leiter LA,VuksanV. 2003a. Differential effects of American ginseng:Abatch of American ginseng (Panax quinquefolius L.) with a depressed ginsenoside profile does not affect postprandial glycemia. Eur J Clin Nutr 57:243-248.
55. Sievenpiper JL, Arnsoson JT, Leiter LA, Vuksan V. 2003b. Possible opposing effects of Asian ginseng (Panax ginseng C.A. Meyer) on glycemia: Results of two acute dose escalation studies. J Am Coll Nutr 22:524-532.
56. Sievenpiper JL, Arnasosn JT, Leiter LA, Vuksan V. 2004a. A quantitative systematic analysis of the literature of the high variability in ginseng (Panax spp.): Should it be trusted? Diabetes Care 27:839-840.
57. Sievenpiper JL, Arnsoson JT, Leiter LA, Vuksan V. 2004b. Decreasing, null, and increasing effects of eight popular types of ginseng on acute postprandial glycemic indices: The role of ginsenosides. J Am Coll Nutr 50:23:248-258.
58. Sievenpiper JL, Sung MK, Di Buono M, Lee KS, Nam KY, Arnason JT, Leiter LA, Vuksan V. 2006. Korean red ginseng rootlets decrease acute postprandial glycemia: results from sequential preparation- and dose-finding studies. J Am Coll Nutr 25:100-107.
59. Soldati F, Tanaka O. 1984. Panax ginseng: Relation between age of plant and content of ginsenosides. Planta Med 50:351-354.
60. Sotaniemi EA, Haapakoski E, Rautio A. 1995. Ginseng therapy in non-insulindependent diabetic patients. Diabetes Care 18:1373-1375.
61. Stavro PM,WooM, HeimT, Leiter LA,VuksanV. 2005. North American ginseng exerts a neutral effect on blood pressure in individuals with hypertension. Hypertension 46:406-411.
62. Stavro PM, Woo M, Heim T, Leiter LA, Vuksan V. 2006. Long-term intake of North American ginseng has no effect on 24-hour blood pressure and renal function. Hypertension 47:791-796.
63. Stavro PM, Woo M, Vuksan V. 2004. Korean red ginseng lowers blood pressure in individuals with hypertension (abstract). Am J Hypertension 17:S33.
64. Stavro PM, Xu Z, Beljan-Zdravkovic U, Jenkins AL, Sievenpiper JL, Vuksan V. 2000. American ginseng improves blood pressure in type 2 diabetes (abstract). Circulation 102:11-417.
65. Sung J, Han KH, Zo JH, Park HJ, Kim CH, Oh BH. 2000. Effects of red ginseng upon vascular endothelial function in patients with essential hypertension. Am J Chin Med 28:205-216.
66. Suzuki Y, Hikino H. 1989. Mechanisms of hypoglycaemic activity of panaxans A and B, glycans of Panax ginseng roots: Effects on plasma level, secretion, sensitivity and binding of insulin in mice. Phytother Res 3:20-24.
67. Suzuki Y, Ito Y, Konno C, Furuya T. 1991. Effects of tissue cultured ginseng on gastric secretion and pepsin activity (Japanese). Yakugaku Zasshi 111:770-774.
68. TawabMA, Bahr U, Karas M,Wurglics M, Schubert-Zsilavecz M. 2003. Degradation of ginsenosides in humans after oral administration. Drug MetabDispos 31:1065-1071.
69. Tchilian EZ, Zhelezarov IE, Hadjiivanova CI. 1991. Effect of ginsenoside Rg1 on insulin binding in mice liver and brain membranes. Phytother Res 5:46-48.
70. Tetsutani T, Yamamura M, Yamaguchi T, Onoyama O, Kono M. 2000. Can red ginseng control blood glucose in diabetic patients. Ginseng Rev 28:44-47.
71. Tomoda M, Hirabayashi K, Shimizu N, Gonda R, Ohara N. 1994. The core structure of ginsenan PA, a phagocytosis-activating polysaccharide from the root of Panax ginseng. Biol Pharm Bull 17:1287-1291.
72. Tomoda M, Hirabayashi K, Shimizu N, Gonda R, Ohara N, Takada K. 1993. Characterization of two novel polysaccharides having immunological activities from the root of Panax ginseng. Biol Pharm Bull 16:1087-1090.
73. Turner RC, Cull CA, Frighi V, Holman RR; UK Prospective Diabetes Study (UKPDS) Group. 1999. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). JAMA 281:2005-2012.
74. Turner RC, Holman R, Stratton I. 1998. Correspondence. Lancet 352:1934.
75. Vuksan V, Jenkins DJA, Spadafora P, Sievenpiper JL, Swilley J, Brighenti F, Josse RG, Leiter L. 1999. Bruce-Thompson C Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes: A randomized controlled metabolic trial. Diabetes Care 22:913-919.
76. Vuksan V, Sievenpiper JL. 2000. The variable effects of whole-leaf digitalis is a paradigm of the glycemic effects of ginseng-Reply. Arch Intern Med 160:3330-3331.
77. Vuksan V, Sievenpiper JL. 2005. Herbal remedies in the management of diabetes: Lessons learned from the study of ginseng. Nutr MetabCardio vasc Dis 15:149-160.
78. Vuksan V, Sievenpiper JL, Beljan-Zdravkovic U, Di Buono M, Stavro PM. 2001c. American ginseng improves lipid control in patients with type 2 diabetes (abstract). FASEB J 15:A632.
79. Vuksan V, Sieveniper JL, Koo VYY, Francis T, Beljan-Zdravkovic U, Xu Z, Vidgen E. 2000a. American ginseng reduces postprandial glycemia in nondiabetic and diabetic individuals. Arch Intern Med 160:1009-1013.
80. Vuksan V, Stavro MP, Sievenpiper JL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Zheng Xu. 2000c. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes. Diabetes Care 23:1221-1226.
81. Vuksan V, Sievenpiper JL,Wong J, Xu Z, Beljan-Zdravkovic U, Arnason JT, Assinewe V, Stavro MP, Jenkins AL, Leiter LA, Francis T. 2001b. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time, but not dose, dependent manner in healthy individuals. Am J Clin Nutr 73:753-758.
82. Vuksan V, Sievenpiper JL, Xu Z, Jenkins AL, Beljan-Zdravkovic U, Leiter LA, Josse RG, Stavro, MP. 2001a. Konjac-mannan and American ginseng: Emerging alternative therapies for type 2 diabetes. J Am Coll Nutr 20:370s-380s.
83. Vuksan V, Stavro MP, Sievenpiper JL, Koo VY,Wong E, Beljan-Zdravkovic U, Francis T, Jenkins AL, Leiter LA, Josse RG, Xu Z. 2000b. American ginseng improves glycemia in individuals with normal glucose tolerance: Effect of dose and time escalation. J Am Coll Nutr 19:738-744.
84. Vuksan V, Sung MK, Sievenpiper JL, Stavro PM, Jenkins AL, Di Buono M, Lee KS, Leiter LA, Nam KY, Arnason JT, Choi M, Naeem A. 2008. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr. Metab. Cardiovasc. Dis. 18:46-56.
85. VuksanV, Xu Z, Sievenpiper JL, StavroMP, Beljan-ZdravkovicU, Di Buono M, Jenkins AL. 2001d. American ginseng improves plasminogen activator inhibitor-1 concentrations in type 2 diabetes (abstract). Diabetes 50:A368.
86. Waki I, Kyo H, Yasuda M, Kimura M. 1982. Effects of a hypoglycemic component of ginseng radix on insulin biosynthesis in normal and diabetic animals. J Pharmacobiodyn 5:547-554.
87. Wang X, Sakuma T, Asafu-Adjaye E, Shiu GK. 1999. Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS. Anal Chem 71:1579-1584.
88. Winslow LC, Shapiro H. 2002. Physicians want education about complementary and alternative medicine to enhance communication with their patients. Arch Intern Med 162:1176-1181.
89. Xie JT, Mehendale SR,Wang A, Hana AH,Wua JA, Osinski J, Yuan CS. 2004. American ginseng leaf: Ginsenoside analysis and hypoglycemic activity. Pharmacol Res 49:113-117.
90. Yamaguchi H, Kasai R, Matsuura H, Tanaka O, Fuwa T. 1988a. High-performance liquid chromatographic analysis of acidic saponins of ginseng and related plants. Chem Pharm Bull 36:3468-3473.
91. Yamamoto A. 2001. Improvement of transmucosal absorption of biologically active peptide drugs. Yakugaku Zasshi 121:929-948.
92. Yamamoto M, Uemura T, Nakama S, Uemiya M, Kumagai A. 1983. Serum HDLcholesterol- increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man. Am J Chin Med 11:96-101.
93. Yamasaki K, Murakami C, Ohtani K, Kasai R, Kurokawa T, Ishibashi S. 1993. Effects of standardized Panax ginseng extract G115 on the D-glucose transport by Ehrlich ascites tumour cells. Phytother Res 7:200-202.
94. Yeh GY, Eisenberg DM, Davis RB, Phillips RS. October 2002. Use of complementary and alternative medicine among persons with diabetes mellitus: Results of a national survey. Am J Public Health 92(10):1648-1652.
95. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS. 2003. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 26:1277-1294.
96. Yokozawa T, Kobayashi T, Kawai A, Oura H, Kawashima Y. 1984. Stimulation of lipid and sugar metabolism in ginsenoside-Rb2 treated rats. Chem Pharm Bull 32:2766-2772.
97. Yokozawa T, Kobayashi T, Oura H, Kawashima Y. 1985. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats. Chem Pharm Bull 33:869-872.
98. Yuan CS, Wu JA, Lowell T, Gu M. 1998. Gut and brain effects of American ginseng root on brainstem neuronal activities in rats. Am J Chin Med 26:47-55. Yushu H, Yuzhen H. 1988. The effect of Panax ginseng extract (GS) on insulin and corticosteroid receptors. J Trad Chin Med 8:292-295.
99. Yushu H, Yuzhen H. 1988. The effect of Panax ginseng extract (GS) on insulin and corticosteroid receptors. J Trad Chin Med 8:292-295.